Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Feb;7(Suppl1):S48-S57.
doi: 10.5152/eurjrheum.2019.19183.

Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties

Affiliations

Linear Scleroderma of the Head - Updates in management of Parry Romberg Syndrome and En coup de sabre: A rapid scoping review across subspecialties

Daniel H Glaser et al. Eur J Rheumatol. 2020 Feb.

Erratum in

  • Erratum.
    [No authors listed] [No authors listed] Eur J Rheumatol. 2020 Jul;7(3):148. doi: 10.5152/eurjrheum.2020.112. Epub 2020 Jul 1. Eur J Rheumatol. 2020. PMID: 32809936 Free PMC article. No abstract available.

Abstract

To provide an update on the current management, including evaluation and treatment, and the available diagnostic tools for linear scleroderma of the head, i.e., Parry-Romberg Syndrome and en coup de sabre (PRS/ECDS). A rapid scoping review of the literature was conducted to include manuscripts published in English between 2010 and 2019. Literature searches were performed in PubMed and EMBASE databases. The were analyzed for descriptive statistic reporting. This study reviewed 215 manuscripts reporting these 1430 patients. Surgical reports comprised the majority of the reviewed literature. Most PRS/ECDS did not appear to receive comprehensive multisubspecialty evaluation for extracutaneous manifestations; 21% of cases noted neurological screening, 4% noted dental screening, and 3% noted ophthalmologic screening. Methotrexate and glucocorticoids remain the most frequent choice for immunosuppressive treatment, though fewer than 7% of patients reported receiving systemic medical therapies. Surgical procedures for cosmetic or functional improvement were common (59%) among the reported patients. Autologous fat grafting was the most frequently utilized cosmetic treatment (50% of procedures) followed by free flap transfers (24% of procedures). There is ongoing need for standardized evaluation, monitoring, and treatment to prevent morbidity in PRS/ECDS, especially in children. When these patients are managed by rheumatologists, methotrexate, and steroids remain the first-line treatment, but a review of the published literature reflects that this may be a minority. Most PRS/ECDS patients are not evaluated in a multidisciplinary fashion. We propose comprehensive evaluations across subspecialties at the baseline and follow-up levels to monitor disease activity and record extracutaneous manifestations, treatment algorithms, and surgical intervention considerations.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflict of interest to declare.

Figures

Figure 1. a–d
Figure 1. a–d
Spectrum of Parry-Romberg syndrome (PRS)/ en coup de sabre (ECDS) patient findings. (a) ECDS lesion of scalp with ipsilateral abnormal T2 signal on brain magnetic resonance imaging (MRI) in a similar plane as the cutaneous findings. (b) PRS/ECDS overlap with skin, soft-tissue, and bone atrophy. (c) PRS/ECDS overlap with single cutaneous band accompanied by significant intraoral manifestations in the same anatomical plane. (d) PRS/ECDS overlap with predominant soft tissue and bone atrophy. “Written publication consent was obtained from the parents of the patients who participated in this study.”
Figure 2
Figure 2
PRISMA flowchart for rapid scoping review process.
Figure 3
Figure 3
Journal topic-category and relative contribution of patient cases. There is apparent over-representation of surgical journals in terms of both publication number and patient cases. Note that journal topic-category may not reflect the medical specialty of the primary authors.
Figure 4
Figure 4
Proposed clinical evaluation, treatment, and monitoring algorithm.

Similar articles

Cited by

References

    1. Torok KS, Li SC, Jacobe HM, Taber SF, Stevens AM, Zulian F, et al. Immunopathogenesis of Pediatric Localized Scleroderma. Front Immunol. 2019;10:908. doi: 10.3389/fimmu.2019.00908. - DOI - PMC - PubMed
    1. Laxer RM, Zulian F. Localized scleroderma. Curr Opin Rheumatol. 2006;18:606–13. doi: 10.1097/01.bor.0000245727.40630.c3. - DOI - PubMed
    1. Li SC. Scleroderma in Children and Adolesecent: Localized Scleroderma and Systemic Sclerosis. Pediatr Clin North Am. 2018;65:757–81. doi: 10.1016/j.pcl.2018.04.002. - DOI - PubMed
    1. Torok KS. Pediatric scleroderma: systemic or localized forms. Pediatr Clin North Am. 2012;59:381–405. doi: 10.1016/j.pcl.2012.03.011. - DOI - PMC - PubMed
    1. Taub P, Torok KS, Schuster L. Hemifacial Atrophy. In: Losee J, editor. Plastic Surgery: Pediatric Plastic Surgery. Elsevier; 2018. pp. 801–14.

Publication types